VISTAGEN THERAPEUTICS INC (VTGN)       0.1521  0 (-1.93%)

0.1521  0 (-1.93%)

US92840H2022 - Common Stock - Premarket: 0.155 +0 (+1.91%)

Buy % Consensus

Analysts have set a mean price target of 0.23. This target is 50.89% above the current price.
VTGN was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about VTGN.
In the previous month the buy percentage consensus was at a similar level.
VTGN was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High - 32.81% 50.89% 50.89% 72.58%

Up and Down Grades

Date Firm Action Rating
2022-07-26 Maxim Group Downgrade Buy -> Hold
2022-07-22 William Blair Downgrade Outperform -> Market Perform
2021-05-20 Baird Initiate Outperform
2021-02-18 Jefferies Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA